Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBM9036 (HL036) Ophthalmic Solution in Dry Eye Disease
CTR20182219Phase 2Completed
- Sponsor
- Harbour BioMed
- Start
- Mar 2019
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of tanfanercept in dry eye syndrome (DED), sponsored by Harbour BioMed. Started Mar 2019; status: completed.
02
Drugs
tanfanercept
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on CTR20182219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20182219.